Advertisement
Advertisement

DVA

DVA logo

DaVita Inc.

180.68
USD
Sponsored
+1.80
+1.01%
Aug 28, 16:00 UTC -4
Closed
exchange

After-Market

181.70

+1.02
+0.56%

DaVita Inc. Profile

About

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.

Info & Links

CEO

Javier J. Rodriguez

Headquarters

2000 16TH STREET
DENVER, CO 80202, UNITED STATES

Industry

Medical Outpatient And Home Healthcare

Sector

Medical

Website

www.davita.com

Auditor

KPMG LLP

Share holders

5,759

Employees

78,000

DaVita Inc. Statistics

Valuation Measures

Market Capitalization2

11.59B

Enterprise Value

21.66B

Enterprise Value/EBITDA(ttm)

7.63

Price to Earnings Ratio(ttm)

13.98

Price to Sales(ttm)

0.81

Price to Book(mrq)

--

Price to Cash(ytd)

8.24

Profitability

Gross Margin(ttm)

32.34%

Operating Margin(ttm)

6.35%

Profit Margin(ttm)

6.03%

Return on Equity(ttm)

-217.63%

Return on Invested Capital(ttm)

11.67%

Return on Assets(ttm)

5.07%

Income Statement

Revenue(ttm)

14.01B

Revenue Per Share(ttm)

219.59

Gross Profit(ttm)

4.53B

EBITDA(ttm)3

2.84B

Net Income Available to Common(ttm)

847.48M

Diluted EPS(ttm)

12.22

Share Statistics

Beta (5Y Monthly)

0.88

52-Week Change

32.82%

S&P 500 52-Week Change

19.58%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

63.80M

Dividend Yield

0.00%

Float4

62.59M

% Held by Insiders

1.90%

% Held by Institutions

90.12%

Balance Sheet

Total Cash(mrq)

771.77M

Total Cash Per Share(mrq)

12.10

Total Debt(mrq)

10.82B

Total Debt/Equity(mrq)

-2244.40%

Current Ratio(mrq)

1.47%

Quick Ratio(mrq)

1.41%

Book Value Per Share(mrq)

-7.54

Cash Flow

Operating Cash Flow Per Share(ytd)

12.27

Free Cash Flow(ytd)

543.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement